Oxybutynin ER 5mg Tablets

Manufacturer KREMERS URBAN Active Ingredient Oxybutynin Extended-Release Tablets(oks i BYOO ti nin) Pronunciation oks i BYOO ti nin
It is used to treat an overactive bladder.It is used in some children to treat a bladder problem called neurogenic detrusor overactivity (NDO).It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Urinary Antispasmodic
đŸ§Ŧ
Pharmacologic Class
Antimuscarinic; Anticholinergic
🤰
Pregnancy Category
Category B
✅
FDA Approved
Jul 1998
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Oxybutynin ER is a medication used to treat overactive bladder symptoms like frequent urination, urgent need to urinate, and leaking urine. It works by relaxing the bladder muscles, helping your bladder hold more urine and reducing the urge to go.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow these steps:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
You can take your medication with or without food.
Take your medication at the same time every day to establish a routine.
Drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Swallow your medication whole, without chewing, breaking, or crushing it.
Take your medication with a full glass of water.
Note that you may see the tablet shell in your stool, but this is a normal occurrence and not a cause for concern.

Storing and Disposing of Your Medication

To ensure the safety and effectiveness of your medication:

Store your medication at room temperature in a dry place, avoiding the bathroom.
Keep all medications in a secure location, out of reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your doctor or pharmacist.
Check with your pharmacist for guidance on the best way to dispose of your medication, and consider participating in a local drug take-back program.

Missing a Dose

If you miss a dose of your medication:

Take the missed dose as soon as you remember.
However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
* Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take the tablet whole with water; do not chew, crush, or break it.
  • Take it at approximately the same time each day.
  • You may see a tablet shell in your stool; this is normal and means the medication has been absorbed.
  • Avoid activities requiring mental alertness (e.g., driving, operating machinery) until you know how the medication affects you, as it can cause dizziness or drowsiness.
  • Be cautious in hot weather or during strenuous exercise, as this medication can decrease sweating and increase the risk of heat stroke. Stay hydrated.
  • Limit alcohol consumption, as it can increase drowsiness.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 5 mg once daily
Dose Range: 5 - 30 mg

Condition-Specific Dosing:

Overactive Bladder (OAB): Initial: 5 mg once daily. May increase in 5 mg increments to a maximum of 30 mg once daily, based on patient response and tolerability.
Neurogenic Detrusor Overactivity (NDO): Initial: 5 mg once daily. May increase in 5 mg increments to a maximum of 30 mg once daily, based on patient response and tolerability.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: For Neurogenic Detrusor Overactivity (NDO) in children â‰Ĩ6 years: Initial 5 mg once daily. May increase in 5 mg increments to a maximum of 20 mg once daily, based on patient response and tolerability.
Adolescent: For Neurogenic Detrusor Overactivity (NDO) in adolescents â‰Ĩ6 years: Initial 5 mg once daily. May increase in 5 mg increments to a maximum of 20 mg once daily, based on patient response and tolerability. For OAB in adolescents â‰Ĩ18 years, adult dosing applies.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, but use with caution.
Moderate: Use with caution. Consider lower initial doses and careful titration.
Severe: Use with caution. Consider lower initial doses and careful titration. Not studied in severe renal impairment.
Dialysis: Not studied. Use with caution.

Hepatic Impairment:

Mild: No specific dose adjustment recommended, but use with caution.
Moderate: Use with caution. Consider lower initial doses and careful titration.
Severe: Not recommended. Not studied in severe hepatic impairment.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Oxybutynin is a competitive antagonist of muscarinic acetylcholine receptors. It exerts a direct antispasmodic effect on the smooth muscle of the detrusor muscle in the bladder, inhibiting the action of acetylcholine at these receptors. This action reduces bladder muscle contractions, increases bladder capacity, and delays the initial desire to void, thereby alleviating symptoms of overactive bladder (urinary urgency, frequency, and urge incontinence).
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 6% for immediate-release (IR) due to extensive first-pass metabolism; higher for extended-release (ER) due to bypass of first-pass metabolism in the upper GI tract, leading to a more consistent absorption profile.
Tmax: Approximately 4-6 hours for oxybutynin and 6-8 hours for its active metabolite (N-desethyloxybutynin) with ER formulation.
FoodEffect: Food does not significantly affect the absorption of oxybutynin from the extended-release tablets.

Distribution:

Vd: Approximately 193 L for oxybutynin and 177 L for N-desethyloxybutynin.
ProteinBinding: Approximately 97% for oxybutynin and 85% for N-desethyloxybutynin.
CnssPenetration: Yes, oxybutynin and its active metabolite can cross the blood-brain barrier, leading to potential CNS side effects.

Elimination:

HalfLife: Approximately 13-16 hours for oxybutynin and 15-18 hours for N-desethyloxybutynin (ER formulation).
Clearance: Plasma clearance is approximately 28.4 L/hr for oxybutynin.
ExcretionRoute: Primarily renal (approximately 50% as metabolites), with a small amount excreted in feces.
Unchanged: Less than 0.1% of the dose is excreted unchanged in urine.
âąī¸

Pharmacodynamics

OnsetOfAction: Within 1 hour (for IR, ER onset is slower due to extended release). Clinical effects may take several days to weeks to optimize.
PeakEffect: Peak plasma concentrations reached in 4-6 hours for ER. Peak clinical effect may be observed after several weeks of consistent dosing.
DurationOfAction: 24 hours (due to extended-release formulation).

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of a urinary tract infection (UTI), including:
+ Blood in the urine
+ Burning or pain when passing urine
+ Frequent or urgent need to pass urine
+ Fever
+ Lower stomach pain
+ Pelvic pain
Severe dizziness or fainting
Confusion
Hallucinations (seeing or hearing things that are not there)
Agitation
Mood changes
Fever
Inability to sweat during physical activity or in warm temperatures
Difficulty passing urine
Severe stomach pain
Muscle weakness
Angioedema, a severe reaction that may be life-threatening, characterized by:
+ Swelling of the hands, face, lips, eyes, tongue, or throat
+ Trouble breathing
+ Trouble swallowing
+ Unusual hoarseness

Other Possible Side Effects

Most people experience few or no side effects when taking this medication. However, if you notice any of the following side effects, contact your doctor or seek medical attention if they bother you or do not go away:

Dizziness
Drowsiness
Fatigue
Weakness
Blurred vision
Headache
Upset stomach
Diarrhea or constipation
Dry mouth
Trouble sleeping
Nervousness or excitability

Reporting Side Effects

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe constipation or abdominal pain (signs of paralytic ileus)
  • Difficulty urinating or inability to urinate (urinary retention)
  • Severe blurred vision or eye pain (signs of angle-closure glaucoma)
  • Confusion, hallucinations, or severe dizziness
  • Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
  • Signs of heat stroke (fever, hot/dry skin, rapid pulse, confusion)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
Certain health conditions, including:
+ Bowel blockage
+ Glaucoma
+ Slow movement of the gastrointestinal (GI) tract
+ Difficulty urinating

This list is not exhaustive, and it is crucial to discuss all your health problems with your doctor.

Additionally, provide your doctor and pharmacist with a comprehensive list of all the medications you are taking, including:
Prescription medications
Over-the-counter (OTC) medications
Natural products
Vitamins

It is vital to verify that it is safe to take this medication in combination with all your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When starting this medication, avoid operating a vehicle or engaging in activities that require alertness and clear vision until you understand how it affects you.

Before consuming alcohol, using marijuana or other cannabis products, or taking prescription or over-the-counter medications that can cause drowsiness, consult with your doctor to discuss potential interactions.

In hot weather or during physical activity, be cautious and drink plenty of fluids to prevent dehydration.

To manage dry mouth, practice good oral hygiene, and consider sucking on hard, sugar-free candy or chewing sugar-free gum. Regular dental check-ups are also recommended.

If you have myasthenia gravis, monitor your condition closely, as this medication may exacerbate your symptoms. If your symptoms worsen, contact your doctor promptly.

Adults 65 years and older should use this medication with caution, as they may be more susceptible to side effects.

This medication is not recommended for children under the age of 6.

If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor to discuss the potential benefits and risks to you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Intensification of anticholinergic effects (e.g., severe dry mouth, blurred vision, dilated pupils, hot/dry skin, flushing)
  • CNS excitation (e.g., restlessness, tremors, irritability, convulsions, delirium, hallucinations)
  • Circulatory disturbances (e.g., tachycardia, hypertension, hypotension, circulatory failure)
  • Respiratory failure
  • Paralysis
  • Coma

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive, including gastric lavage, activated charcoal, and physostigmine for severe anticholinergic symptoms.

Drug Interactions

🔴

Major Interactions

  • Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir): May significantly increase oxybutynin plasma concentrations, leading to increased anticholinergic side effects. Co-administration should be avoided or used with extreme caution with dose reduction.
  • Other anticholinergic agents (e.g., atropine, scopolamine, tricyclic antidepressants, phenothiazines, antihistamines): May potentiate anticholinergic effects (dry mouth, constipation, blurred vision, CNS effects) and increase risk of heat prostration.
🟡

Moderate Interactions

  • Drugs that slow gastrointestinal motility (e.g., opioids, metoclopramide, prokinetic agents): May reduce the absorption of other orally administered drugs due to prolonged GI transit time. Oxybutynin itself can slow GI motility.
  • Cholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine): Oxybutynin may antagonize the effects of cholinesterase inhibitors, potentially reducing their efficacy in Alzheimer's disease.
đŸŸĸ

Minor Interactions

  • Alcohol: May enhance the sedative effects of oxybutynin.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Baseline bladder diary

Rationale: To assess baseline urinary frequency, urgency, and incontinence episodes for efficacy monitoring.

Timing: Prior to initiation of therapy.

Renal and Hepatic Function

Rationale: To identify potential impairment that may necessitate dose adjustment or increased monitoring due to altered drug metabolism/excretion.

Timing: Prior to initiation, especially in elderly or those with suspected impairment.

📊

Routine Monitoring

Efficacy (symptom improvement)

Frequency: Regularly, typically at follow-up visits (e.g., 2-4 weeks after initiation or dose change, then every 3-6 months).

Target: Reduction in urinary frequency, urgency, and incontinence episodes.

Action Threshold: Lack of improvement or worsening symptoms may indicate need for dose adjustment or alternative therapy.

Adverse effects (e.g., dry mouth, constipation, blurred vision, CNS effects)

Frequency: Regularly, especially during dose titration and at follow-up visits.

Target: Tolerable level of side effects.

Action Threshold: Intolerable side effects may require dose reduction or discontinuation.

Post-void residual (PVR) volume

Frequency: Periodically, especially in patients at risk for urinary retention (e.g., BPH, bladder outlet obstruction).

Target: <100-150 mL (generally).

Action Threshold: Significant increase in PVR (>200 mL) may indicate urinary retention and necessitate discontinuation.

đŸ‘ī¸

Symptom Monitoring

  • Dry mouth
  • Constipation
  • Blurred vision
  • Dizziness
  • Somnolence
  • Headache
  • Nausea
  • Urinary retention
  • Signs of heat prostration (e.g., fever, hot/dry skin, confusion, rapid pulse) in hot environments.

Special Patient Groups

🤰

Pregnancy

Oxybutynin is Pregnancy Category B. Animal studies have not shown harm to the fetus, but there are no adequate and well-controlled studies in pregnant women. Use only if clearly needed.

Trimester-Specific Risks:

First Trimester: No increased risk of congenital anomalies observed in animal studies.
Second Trimester: No specific risks identified beyond general pregnancy considerations.
Third Trimester: No specific risks identified beyond general pregnancy considerations.
🤱

Lactation

Oxybutynin and its active metabolite are excreted into breast milk. The amount is small, but potential for anticholinergic effects in the infant exists (e.g., sedation, constipation). Use with caution; monitor infant for adverse effects. L3 (Moderately safe).

Infant Risk: Low to moderate risk of anticholinergic effects (e.g., drowsiness, constipation, dry mouth) in the infant. Monitor for these symptoms.
đŸ‘ļ

Pediatric Use

Approved for neurogenic detrusor overactivity in children â‰Ĩ6 years. Safety and efficacy for overactive bladder (OAB) in children <18 years have not been established. Children may be more susceptible to anticholinergic side effects.

👴

Geriatric Use

Elderly patients may be more sensitive to the anticholinergic effects of oxybutynin, particularly CNS effects (e.g., confusion, hallucinations, dizziness, somnolence). Lower initial doses and careful titration are recommended. Increased risk of falls due to dizziness/blurred vision.

Clinical Information

💎

Clinical Pearls

  • The extended-release (ER) formulation of oxybutynin is generally associated with a lower incidence of dry mouth compared to the immediate-release (IR) formulation, due to lower peak plasma concentrations.
  • Patients should be advised that the tablet shell may be visible in their stool, which is a normal occurrence and does not mean the medication was not absorbed.
  • Oxybutynin ER should be swallowed whole and not chewed, crushed, or divided, as this would disrupt the extended-release mechanism and could lead to rapid absorption and increased side effects.
  • Consider alternative agents (e.g., beta-3 agonists like mirabegron) for patients who cannot tolerate anticholinergic side effects or have contraindications to anticholinergics (e.g., uncontrolled narrow-angle glaucoma, urinary retention).
🔄

Alternative Therapies

  • Other antimuscarinics: Tolterodine (Detrol, Detrol LA), Solifenacin (Vesicare), Fesoterodine (Toviaz), Darifenacin (Enablex), Trospium (Sanctura, Sanctura XR)
  • Beta-3 adrenergic agonists: Mirabegron (Myrbetriq), Vibegron (Gemtesa)
  • OnabotulinumtoxinA (Botox) intravesical injection
  • Percutaneous tibial nerve stimulation (PTNS)
  • Sacral neuromodulation (SNS)
  • Behavioral therapies (e.g., bladder training, pelvic floor muscle exercises)
💰

Cost & Coverage

Average Cost: Varies widely, typically $30-$150 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the medication taken, the amount, and the time it occurred.